Propanc Biopharma's three largest insider shareholders as of March 23, 2026 are Julian Norman Kenyon (Chief Scientific Officer, 3.42Mn shares), James Andrew Nathanielsz (Ceo/Cfo, 2.80Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Julian Norman Kenyon | Chief Scientific Officer | 3,420,005 | 0 | 19 Aug, 2021 |
| James Andrew Nathanielsz | Ceo/Cfo | 0 | 2,800,000 | 19 Aug, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 05 Jul, 2023 | Josef Zelinger | Common Stock Purchase Warrant | A | 15,000,000 | $0.00 | 15,000,000 | I | A |
| 17 Aug, 2021 | Julian Norman Kenyon | Common stock, par value $0.001 | A | 3,420,000 | $0.00 | 3,420,005 | D | A |
| 17 Aug, 2021 | James Andrew Nathanielsz | Common stock, par value $0.001 | A | 5,928,000 | $0.00 | 5,928,004 | I | A |
| 17 Aug, 2021 | James Andrew Nathanielsz | Common stock, par value $0.001 | A | 2,800,000 | $0.00 | 2,800,000 | I | A |
| 14 May, 2019 | Julian Norman Kenyon | Stock Options (Right to Buy) | A | 9,750,000 | $0.00 | 9,750,000 | D | A |
| 14 May, 2019 | Julian Norman Kenyon | Restricted Stock Units | A | 9,750,000 | $0.00 | 9,750,000 | D | A |
| 14 May, 2019 | Julian Norman Kenyon | Restricted Stock Units | A | 9,750,000 | $0.00 | 9,750,000 | D | A |
| 14 May, 2019 | James Andrew Nathanielsz | Stock Options (Right to Buy) | A | 19,500,000 | $0.00 | 19,500,000 | D | A |
| 14 May, 2019 | James Andrew Nathanielsz | Restricted Stock Units | A | 19,500,000 | $0.00 | 19,500,000 | D | A |
| 14 May, 2019 | James Andrew Nathanielsz | Restricted Stock Units | A | 19,500,000 | $0.00 | 19,500,000 | D | A |
| 23 Aug, 2012 | James Andrew Nathanielsz | Common Stock | D | 250,000 | $0.20 | 9,782,261 | I | P |